A one-size-fits-all polypill strategy for primary prevention in the era of precision medicine?
- PMID: 33471085
- DOI: 10.1093/eurheartj/ehaa1064
A one-size-fits-all polypill strategy for primary prevention in the era of precision medicine?
Comment on
-
Polypill with or without Aspirin in Persons without Cardiovascular Disease.N Engl J Med. 2021 Jan 21;384(3):216-228. doi: 10.1056/NEJMoa2028220. Epub 2020 Nov 13. N Engl J Med. 2021. PMID: 33186492 Free PMC article. Clinical Trial.
Similar articles
-
The Fuster-CNIC-Ferrer Cardiovascular Polypill: a polypill for secondary cardiovascular prevention.Int J Cardiol. 2015 Dec;201 Suppl 1:S15-22. doi: 10.1016/S0167-5273(15)31028-7. Int J Cardiol. 2015. PMID: 26747390 Review.
-
Cost-effectiveness and public health benefit of secondary cardiovascular disease prevention from improved adherence using a polypill in the UK.BMJ Open. 2015 May 9;5(5):e007111. doi: 10.1136/bmjopen-2014-007111. BMJ Open. 2015. PMID: 25991449 Free PMC article.
-
Embracing the polypill as a cardiovascular therapeutic: is this the best strategy?Expert Opin Pharmacother. 2018 Dec;19(17):1857-1865. doi: 10.1080/14656566.2018.1532501. Epub 2018 Oct 9. Expert Opin Pharmacother. 2018. PMID: 30295098
-
Aspirin for primary cardiovascular disease prevention: time to re-evaluate guidelines?Intern Med J. 2019 Jan;49(1):133-134. doi: 10.1111/imj.14185. Intern Med J. 2019. PMID: 30680892 No abstract available.
-
Polypill strategy for primary prevention of cardiovascular disorders.Drugs Today (Barc). 2013 May;49(5):317-24. doi: 10.1358/dot.2013.49.5.1950148. Drugs Today (Barc). 2013. PMID: 23724411 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources